SCHEMBL7308749

SCHEMBL7308749

CCOC(=O)Cc1csc(NC(=O)C(N)Cc2ccccc2)n1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.64
TP53 P04637 1/20 0.64
HSD17B10 Q99714 1/20 0.62
ALDH1A1 P00352 6/20 0.61
NPC1 O15118 3/20 0.60
RAB9A P51151 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
HTT P42858 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
MAPT P10636 2/20 0.59
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
GAA P10253 1/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
POLB P06746 1/20 0.56
ESR2 Q92731 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7304548 0.99 LMNA (0.62) LMNATP53HSD17B10ALDH1A1NPC1
SCHEMBL7307483 0.90 MAPT (0.65) LMNATP53ALDH1A1NPC1RAB9A
SCHEMBL7310616 0.86 KMT2A (0.71) LMNATP53ALDH1A1NPC1RAB9A
SCHEMBL7306294 0.85 MME (0.49) LMNATP53HSD17B10ALDH1A1MEN1
SCHEMBL7348891 0.84 LMNA (0.57) LMNATP53HSD17B10ALDH1A1NPC1
SCHEMBL7303833 0.83 LMNA (0.58) LMNATP53HSD17B10ALDH1A1NPC1
SCHEMBL2753912 0.83 LMNA (0.69) LMNATP53HSD17B10ALDH1A1NPC1
SCHEMBL7307895 0.82 LMNA (0.55) LMNATP53HSD17B10ALDH1A1NPC1
SCHEMBL7308841 0.82 LMNA (0.56) LMNATP53HSD17B10ALDH1A1NPC1
SCHEMBL11325003 0.81 MAPK1 (0.67) LMNATP53HSD17B10ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0636630-B1 N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases ZAMBON SPA (IT) 1999-04-28 EP disclosed
US-5438046-A Enzyme inhibitors ZAMBON GROUP S.P.A. (IT) 1995-08-01 US disclosed
EP-0636630-A1 N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases ZAMBON GROUP S.p.A. (IT) 1995-02-01 EP disclosed